Inflammatory biomarkers in osteoarthritis
1Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.
Osteoarthritis and Cartilage
|November 3, 2015
Summary
Osteoarthritis (OA) is increasingly understood as an inflammatory condition, not just "wear and tear." Biomarkers offer a promising avenue for detecting early inflammation in OA, aiding clinical diagnosis.
Area of Science:
- Rheumatology
- Biochemistry
- Medical Diagnostics
Background:
- Osteoarthritis (OA) is a prevalent global cause of disability.
- Current diagnostic and treatment options for early-stage OA are limited.
- Emerging research reframes OA as an inflammatory disease.
Purpose of the Study:
- To review biomarkers associated with inflammation in human osteoarthritis (OA) studies.
- To highlight the potential of biomarkers for identifying subclinical OA inflammation.
- To discuss the clinical applicability of inflammation-based OA biomarkers.
Main Methods:
- Review of human studies investigating osteoarthritis biomarkers.
- Analysis of evidence from MRI, ultrasound, histochemistry, and biochemical markers.
- Synthesis of findings related to inflammation in OA pathogenesis.
Main Results:
- Multiple biomarkers indicate a significant role of inflammation in OA.
- Biomarkers can potentially detect subclinical or sub-acute inflammatory changes.
- Various imaging and molecular techniques support the inflammatory basis of OA.
Conclusions:
- Inflammation is a key factor in osteoarthritis.
- Biomarkers are crucial for advancing early OA detection and management.
- Further research into clinical applications of OA biomarkers is warranted.
